SG11201909368TA - Compositions and systems for renal function determination - Google Patents
Compositions and systems for renal function determinationInfo
- Publication number
- SG11201909368TA SG11201909368TA SG11201909368TA SG11201909368TA SG 11201909368T A SG11201909368T A SG 11201909368TA SG 11201909368T A SG11201909368T A SG 11201909368TA SG 11201909368T A SG11201909368T A SG 11201909368TA
- Authority
- SG
- Singapore
- Prior art keywords
- louis
- international
- missouri
- suite
- square drive
- Prior art date
Links
- 230000003907 kidney function Effects 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 230000005670 electromagnetic radiation Effects 0.000 abstract 2
- 230000024924 glomerular filtration Effects 0.000 abstract 2
- 241000699729 Muridae Species 0.000 abstract 1
- 230000007423 decrease Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 239000000700 radioactive tracer Substances 0.000 abstract 1
- 102220240796 rs553605556 Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1495—Calibrating or testing of in-vivo probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/201—Assessing renal or kidney functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6814—Head
- A61B5/6815—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B57/00—Other synthetic dyes of known constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0093—Detecting, measuring or recording by applying one single type of energy and measuring its conversion into another type of energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Physiology (AREA)
- Signal Processing (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Artificial Intelligence (AREA)
- Otolaryngology (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762577962P | 2017-10-27 | 2017-10-27 | |
PCT/US2018/057820 WO2019084475A1 (en) | 2017-10-27 | 2018-10-26 | COMPOSITIONS AND SYSTEMS FOR MEASURING RENAL FUNCTION |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201909368TA true SG11201909368TA (en) | 2019-11-28 |
Family
ID=66245914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201909368T SG11201909368TA (en) | 2017-10-27 | 2018-10-26 | Compositions and systems for renal function determination |
Country Status (16)
Country | Link |
---|---|
US (2) | US11602570B2 (es) |
EP (1) | EP3700578A4 (es) |
JP (3) | JP7202355B2 (es) |
KR (3) | KR20230054506A (es) |
CN (1) | CN110494167A (es) |
AU (1) | AU2018355541B2 (es) |
BR (1) | BR112019020605A2 (es) |
CA (1) | CA3058772C (es) |
IL (2) | IL269617B1 (es) |
MX (2) | MX2019011977A (es) |
MY (1) | MY197859A (es) |
NZ (1) | NZ757917A (es) |
PH (1) | PH12019502352A1 (es) |
RU (2) | RU2021133174A (es) |
SG (1) | SG11201909368TA (es) |
WO (1) | WO2019084475A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3072427C (en) | 2017-08-08 | 2023-12-05 | Fresenius Medical Care Holdings, Inc. | Systems and methods for treating and estimating progression of chronic kidney disease |
US20200187838A1 (en) * | 2018-12-12 | 2020-06-18 | Medibeacon Inc. | Uses of transdermal glomerular filtration rate measurement in continuous renal replacement therapy |
EP4185194A4 (en) * | 2020-07-24 | 2024-07-24 | Medibeacon Inc | SYSTEMS AND METHODS FOR TRANSDERMAL HOME ASSESSMENT OF GASTROINTESTINAL FUNCTION |
JP2024512916A (ja) * | 2021-03-31 | 2024-03-21 | メディビーコン,インク. | 置換ジアミノピラジンジカルボン酸の精製 |
WO2023016483A1 (zh) * | 2021-08-11 | 2023-02-16 | 杭州中美华东制药有限公司 | 制备作为荧光示踪剂的吡嗪羧酸类衍生物的方法 |
TW202319052A (zh) * | 2021-08-27 | 2023-05-16 | 中國大陸商杭州中美華東製藥有限公司 | 吡嗪類衍生物的晶型及其製備方法 |
CN118103355A (zh) * | 2021-09-24 | 2024-05-28 | 杭州中美华东制药有限公司 | 用于制备作为荧光示踪剂的吡嗪羧酸类衍生物的氢化合成方法 |
WO2023078440A1 (zh) * | 2021-11-08 | 2023-05-11 | 杭州中美华东制药有限公司 | 吡嗪类衍生物的盐的晶型及其制备方法 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5301673A (en) * | 1991-11-18 | 1994-04-12 | Massachusetts General Hospital | Ambulatory clearance function monitor |
US6280703B1 (en) | 1997-03-13 | 2001-08-28 | Mallinckrodt Inc. | Simultaneous multimodal measurement of physiological function |
US6909912B2 (en) | 2002-06-20 | 2005-06-21 | University Of Florida | Non-invasive perfusion monitor and system, specially configured oximeter probes, methods of using same, and covers for probes |
ATE539674T1 (de) | 2003-04-24 | 2012-01-15 | Univ Texas | Nichtinvasive blutanalyse durch optische sondierung der venen unter der zunge |
US20060095102A1 (en) | 2003-09-17 | 2006-05-04 | Thomas Perez | Method and apparatus for sublingual application of light to blood |
CA2592021A1 (en) * | 2004-12-23 | 2006-07-06 | Raghavan Rajagopalan | Fluorescent pyrazine derivatives and methods of using the same in assessing renal function |
US8664392B2 (en) | 2004-12-23 | 2014-03-04 | Medibeacon, LLC | Pyrazine derivatives for bioconjugation |
US7710872B2 (en) | 2005-12-14 | 2010-05-04 | Cisco Technology, Inc. | Technique for enabling traffic engineering on CE-CE paths across a provider network |
CN101267844A (zh) | 2006-02-24 | 2008-09-17 | 马林克罗特公司 | 使用光学试剂的方法 |
CA2628661A1 (en) * | 2006-06-22 | 2007-12-27 | Mallinckrodt Inc. | Pyrazine derivatives and uses thereof in renal monitoring |
EP2038261A2 (en) | 2006-06-22 | 2009-03-25 | Mallinckrodt Inc. | Pyrazine derivatives with extended conjugation and uses thereof |
US8591865B2 (en) * | 2008-04-18 | 2013-11-26 | Pharmacophotonics, Inc. | Renal function analysis method and apparatus |
AU2009246777A1 (en) * | 2008-04-18 | 2009-11-19 | Pharmacophotonics, Inc. | Renal function analysis method and apparatus |
US8697033B2 (en) * | 2008-12-17 | 2014-04-15 | Medibeacon, LLC | Modified pyrazine derivatives and uses thereof |
US9554739B2 (en) | 2009-09-29 | 2017-01-31 | Covidien Lp | Smart cable for coupling a medical sensor to an electronic patient monitor |
US20120172678A1 (en) | 2010-12-30 | 2012-07-05 | Logan Robert J | Systems and methods for monitoring and processing biometric data |
US9795296B2 (en) | 2011-04-26 | 2017-10-24 | Incube Labs, Llc | Mouthpiece for measurement of biometric data of a diver and underwater communication |
WO2013170219A1 (en) * | 2012-05-11 | 2013-11-14 | BioMetric Holdings, Inc. | Systems, methods, and apparatuses for monitoring end stage renal disease |
JP6506275B2 (ja) * | 2013-10-22 | 2019-04-24 | メディビーコン,インク. | 改善された経皮臓器機能測定 |
US11077211B2 (en) * | 2013-11-11 | 2021-08-03 | Medibeacon Inc. | Compositions and methods for assessing gut function |
JP2016112375A (ja) | 2014-12-16 | 2016-06-23 | イオム株式会社 | 皮膚蛍光測定装置 |
WO2016183351A1 (en) | 2015-05-12 | 2016-11-17 | Medibeacon Inc. | Compositions and methods for assessing eye vasculature |
CA3203465A1 (en) * | 2017-01-30 | 2018-08-02 | Medibeacon Inc. | Method for non-invasive monitoring of fluorescent tracer agent with diffuse reflection corrections |
BR112019021040A2 (pt) * | 2017-10-27 | 2020-05-12 | Medibeacon Inc. | Métodos para determinação da função renal |
-
2018
- 2018-10-26 EP EP18870574.3A patent/EP3700578A4/en active Pending
- 2018-10-26 MX MX2019011977A patent/MX2019011977A/es unknown
- 2018-10-26 WO PCT/US2018/057820 patent/WO2019084475A1/en active Search and Examination
- 2018-10-26 KR KR1020237012662A patent/KR20230054506A/ko active IP Right Grant
- 2018-10-26 SG SG11201909368T patent/SG11201909368TA/en unknown
- 2018-10-26 IL IL269617A patent/IL269617B1/en unknown
- 2018-10-26 JP JP2020504300A patent/JP7202355B2/ja active Active
- 2018-10-26 US US16/171,689 patent/US11602570B2/en active Active
- 2018-10-26 KR KR1020197030121A patent/KR20200010191A/ko not_active IP Right Cessation
- 2018-10-26 MY MYPI2019006091A patent/MY197859A/en unknown
- 2018-10-26 AU AU2018355541A patent/AU2018355541B2/en active Active
- 2018-10-26 KR KR1020217043268A patent/KR20220003659A/ko not_active IP Right Cessation
- 2018-10-26 RU RU2021133174A patent/RU2021133174A/ru unknown
- 2018-10-26 RU RU2019132431A patent/RU2760279C2/ru active
- 2018-10-26 NZ NZ757917A patent/NZ757917A/en unknown
- 2018-10-26 IL IL312255A patent/IL312255A/en unknown
- 2018-10-26 CN CN201880009623.1A patent/CN110494167A/zh active Pending
- 2018-10-26 BR BR112019020605A patent/BR112019020605A2/pt unknown
- 2018-10-26 CA CA3058772A patent/CA3058772C/en active Active
-
2019
- 2019-10-04 MX MX2023011017A patent/MX2023011017A/es unknown
- 2019-10-16 PH PH12019502352A patent/PH12019502352A1/en unknown
-
2022
- 2022-09-28 JP JP2022155098A patent/JP7362869B2/ja active Active
-
2023
- 2023-01-31 US US18/162,163 patent/US20230173111A1/en active Pending
- 2023-10-04 JP JP2023172653A patent/JP2023175915A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US11602570B2 (en) | 2023-03-14 |
AU2018355541A1 (en) | 2019-10-31 |
MX2023011017A (es) | 2023-09-27 |
IL269617A (en) | 2019-11-28 |
BR112019020605A2 (pt) | 2020-04-22 |
RU2021133174A (ru) | 2021-12-02 |
MY197859A (en) | 2023-07-20 |
NZ757917A (en) | 2022-04-29 |
JP2020516680A (ja) | 2020-06-11 |
MX2019011977A (es) | 2020-01-27 |
JP2023009041A (ja) | 2023-01-19 |
IL269617B1 (en) | 2024-05-01 |
RU2019132431A3 (es) | 2021-04-14 |
CA3058772C (en) | 2023-08-08 |
IL312255A (en) | 2024-06-01 |
PH12019502352A1 (en) | 2020-12-07 |
EP3700578A1 (en) | 2020-09-02 |
KR20200010191A (ko) | 2020-01-30 |
JP7202355B2 (ja) | 2023-01-11 |
RU2019132431A (ru) | 2021-04-14 |
KR20220003659A (ko) | 2022-01-10 |
WO2019084475A1 (en) | 2019-05-02 |
EP3700578A4 (en) | 2021-08-04 |
RU2760279C2 (ru) | 2021-11-23 |
US20230173111A1 (en) | 2023-06-08 |
AU2018355541B2 (en) | 2020-11-19 |
US20190125901A1 (en) | 2019-05-02 |
JP2023175915A (ja) | 2023-12-12 |
CA3058772A1 (en) | 2019-05-02 |
JP7362869B2 (ja) | 2023-10-17 |
KR20230054506A (ko) | 2023-04-24 |
CN110494167A (zh) | 2019-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201909368TA (en) | Compositions and systems for renal function determination | |
SG11201909367VA (en) | Methods for renal function determination | |
SG11201804086VA (en) | Methods and compositions for nucleic acid analysis | |
SG11201805217XA (en) | Compositions and methods for the treatment of hemoglobinopathies | |
SG11201807002TA (en) | Intention signaling for an autonomous vehicle | |
SG11201908719QA (en) | Biomarkers and car t cell therapies with enhanced efficacy | |
SG11201803983UA (en) | Transformable tagging compositions, methods, and processes incorporating same | |
SG11202000145XA (en) | Methods and systems for conditionally regulating gene expression | |
SG11201901364VA (en) | Engineered target specific nucleases | |
SG11201901531TA (en) | Regulation of gene expression using engineered nucleases | |
SG11201809437TA (en) | Intracellular delivery of biomolecules to induce tolerance | |
SG11201900274VA (en) | Event trigger for independent links | |
SG11201908847TA (en) | Apparatuses, systems and methods for imaging flow cytometry | |
SG11201804528YA (en) | Multi-passenger ride vehicle | |
SG11201906824QA (en) | Apparatus, method, and system for alignment of 3d datasets | |
SG11201906372PA (en) | Computer-implemented system and method for generating and extracting user related data stored on a blockchain | |
SG11201903958SA (en) | Intuitive occluded object indicator | |
SG11201811034PA (en) | Air treatment systems and methods | |
SG11201901020RA (en) | Anti-siglec-7 antibodies for the treatment of cancer | |
SG11201805422WA (en) | Multivalent and multispecific ox40-binding fusion proteins | |
SG11201811426UA (en) | Distributed electronic record and transaction history | |
SG11201909011PA (en) | Niraparib compositions | |
SG11201907776WA (en) | Replication lag-constrained deletion of data in a large-scale distributed data storage system | |
SG11201805874VA (en) | Method and apparatus for adding notification objects | |
CA3025288C (en) | Reduced misting alkaline and neutral cleaning, sanitizing, and disinfecting compositions via the use of high molecular weight water-in-oil emulsion polymers |